IBDEI0NC ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29563,0)
 ;;=L68.0^^83^1275^2
 ;;^UTILITY(U,$J,358.3,29563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29563,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,29563,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,29563,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,29564,0)
 ;;=E28.1^^83^1275^3
 ;;^UTILITY(U,$J,358.3,29564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29564,1,3,0)
 ;;=3^Hyperandrogenism
 ;;^UTILITY(U,$J,358.3,29564,1,4,0)
 ;;=4^E28.1
 ;;^UTILITY(U,$J,358.3,29564,2)
 ;;=^5002748
 ;;^UTILITY(U,$J,358.3,29565,0)
 ;;=E22.1^^83^1275^4
 ;;^UTILITY(U,$J,358.3,29565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29565,1,3,0)
 ;;=3^Hyperprolactinemia
 ;;^UTILITY(U,$J,358.3,29565,1,4,0)
 ;;=4^E22.1
 ;;^UTILITY(U,$J,358.3,29565,2)
 ;;=^60265
 ;;^UTILITY(U,$J,358.3,29566,0)
 ;;=E05.90^^83^1275^5
 ;;^UTILITY(U,$J,358.3,29566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29566,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,29566,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,29566,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,29567,0)
 ;;=E03.9^^83^1275^6
 ;;^UTILITY(U,$J,358.3,29567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29567,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,29567,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,29567,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,29568,0)
 ;;=E04.0^^83^1275^7
 ;;^UTILITY(U,$J,358.3,29568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29568,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,29568,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,29568,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,29569,0)
 ;;=E89.0^^83^1275^8
 ;;^UTILITY(U,$J,358.3,29569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29569,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,29569,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,29569,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,29570,0)
 ;;=D35.2^^83^1275^9
 ;;^UTILITY(U,$J,358.3,29570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29570,1,3,0)
 ;;=3^Prolactinoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,29570,1,4,0)
 ;;=4^D35.2
 ;;^UTILITY(U,$J,358.3,29570,2)
 ;;=^5002145
 ;;^UTILITY(U,$J,358.3,29571,0)
 ;;=Z13.1^^83^1275^10
 ;;^UTILITY(U,$J,358.3,29571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29571,1,3,0)
 ;;=3^Screen,Diabetes
 ;;^UTILITY(U,$J,358.3,29571,1,4,0)
 ;;=4^Z13.1
 ;;^UTILITY(U,$J,358.3,29571,2)
 ;;=^5062700
 ;;^UTILITY(U,$J,358.3,29572,0)
 ;;=Z13.220^^83^1275^11
 ;;^UTILITY(U,$J,358.3,29572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29572,1,3,0)
 ;;=3^Screen,Lipids
 ;;^UTILITY(U,$J,358.3,29572,1,4,0)
 ;;=4^Z13.220
 ;;^UTILITY(U,$J,358.3,29572,2)
 ;;=^5062702
 ;;^UTILITY(U,$J,358.3,29573,0)
 ;;=Z13.29^^83^1275^12
 ;;^UTILITY(U,$J,358.3,29573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29573,1,3,0)
 ;;=3^Screen,Thyroid
 ;;^UTILITY(U,$J,358.3,29573,1,4,0)
 ;;=4^Z13.29
 ;;^UTILITY(U,$J,358.3,29573,2)
 ;;=^5062704
 ;;^UTILITY(U,$J,358.3,29574,0)
 ;;=N70.01^^83^1276^12
 ;;^UTILITY(U,$J,358.3,29574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29574,1,3,0)
 ;;=3^Salpingitis,Acute
 ;;^UTILITY(U,$J,358.3,29574,1,4,0)
 ;;=4^N70.01
 ;;^UTILITY(U,$J,358.3,29574,2)
 ;;=^5015802
 ;;^UTILITY(U,$J,358.3,29575,0)
 ;;=A63.0^^83^1276^19
 ;;^UTILITY(U,$J,358.3,29575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29575,1,3,0)
 ;;=3^Verereal Warts
 ;;^UTILITY(U,$J,358.3,29575,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,29575,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,29576,0)
 ;;=B37.3^^83^1276^1
 ;;^UTILITY(U,$J,358.3,29576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29576,1,3,0)
 ;;=3^Candidiasis
 ;;^UTILITY(U,$J,358.3,29576,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,29576,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,29577,0)
 ;;=N72.^^83^1276^2
 ;;^UTILITY(U,$J,358.3,29577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29577,1,3,0)
 ;;=3^Cervicitis
 ;;^UTILITY(U,$J,358.3,29577,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,29577,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,29578,0)
 ;;=A74.89^^83^1276^3
 ;;^UTILITY(U,$J,358.3,29578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29578,1,3,0)
 ;;=3^Chlamydia (Culture +)
 ;;^UTILITY(U,$J,358.3,29578,1,4,0)
 ;;=4^A74.89
 ;;^UTILITY(U,$J,358.3,29578,2)
 ;;=^5000387
 ;;^UTILITY(U,$J,358.3,29579,0)
 ;;=Z11.8^^83^1276^13
 ;;^UTILITY(U,$J,358.3,29579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29579,1,3,0)
 ;;=3^Screen,Chlamydia
 ;;^UTILITY(U,$J,358.3,29579,1,4,0)
 ;;=4^Z11.8
 ;;^UTILITY(U,$J,358.3,29579,2)
 ;;=^5062677
 ;;^UTILITY(U,$J,358.3,29580,0)
 ;;=A56.02^^83^1276^4
 ;;^UTILITY(U,$J,358.3,29580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29580,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29580,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,29580,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,29581,0)
 ;;=Z20.2^^83^1276^5
 ;;^UTILITY(U,$J,358.3,29581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29581,1,3,0)
 ;;=3^Contact with/Exposure to Infection,Sexual Mode of Transmission
 ;;^UTILITY(U,$J,358.3,29581,1,4,0)
 ;;=4^Z20.2
 ;;^UTILITY(U,$J,358.3,29581,2)
 ;;=^5062764
 ;;^UTILITY(U,$J,358.3,29582,0)
 ;;=N71.9^^83^1276^6
 ;;^UTILITY(U,$J,358.3,29582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29582,1,3,0)
 ;;=3^Endometritis
 ;;^UTILITY(U,$J,358.3,29582,1,4,0)
 ;;=4^N71.9
 ;;^UTILITY(U,$J,358.3,29582,2)
 ;;=^5015811
 ;;^UTILITY(U,$J,358.3,29583,0)
 ;;=A54.00^^83^1276^7
 ;;^UTILITY(U,$J,358.3,29583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29583,1,3,0)
 ;;=3^Gonorrhea (Culture +),Lower GU Tract
 ;;^UTILITY(U,$J,358.3,29583,1,4,0)
 ;;=4^A54.00
 ;;^UTILITY(U,$J,358.3,29583,2)
 ;;=^5000311
 ;;^UTILITY(U,$J,358.3,29584,0)
 ;;=Z11.3^^83^1276^14
 ;;^UTILITY(U,$J,358.3,29584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29584,1,3,0)
 ;;=3^Screen,Gonorrhea
 ;;^UTILITY(U,$J,358.3,29584,1,4,0)
 ;;=4^Z11.3
 ;;^UTILITY(U,$J,358.3,29584,2)
 ;;=^5062672
 ;;^UTILITY(U,$J,358.3,29585,0)
 ;;=A60.04^^83^1276^8
 ;;^UTILITY(U,$J,358.3,29585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29585,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29585,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,29585,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,29586,0)
 ;;=N89.8^^83^1276^9
 ;;^UTILITY(U,$J,358.3,29586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29586,1,3,0)
 ;;=3^Leukorrhea
 ;;^UTILITY(U,$J,358.3,29586,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,29586,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,29587,0)
 ;;=N73.0^^83^1276^10
 ;;^UTILITY(U,$J,358.3,29587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29587,1,3,0)
 ;;=3^Pelvic Cellulitis
 ;;^UTILITY(U,$J,358.3,29587,1,4,0)
 ;;=4^N73.0
 ;;^UTILITY(U,$J,358.3,29587,2)
 ;;=^270467
 ;;^UTILITY(U,$J,358.3,29588,0)
 ;;=T81.4XXD^^83^1276^11
 ;;^UTILITY(U,$J,358.3,29588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29588,1,3,0)
 ;;=3^Post-op Wound Infection,Subs Encntr
 ;;^UTILITY(U,$J,358.3,29588,1,4,0)
 ;;=4^T81.4XXD
 ;;^UTILITY(U,$J,358.3,29588,2)
 ;;=^5054480
 ;;^UTILITY(U,$J,358.3,29589,0)
 ;;=N76.1^^83^1276^17
 ;;^UTILITY(U,$J,358.3,29589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29589,1,3,0)
 ;;=3^Vaginitis,Subacute and Chronic
 ;;^UTILITY(U,$J,358.3,29589,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,29589,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,29590,0)
 ;;=A53.9^^83^1276^15
 ;;^UTILITY(U,$J,358.3,29590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29590,1,3,0)
 ;;=3^Syphilis
 ;;^UTILITY(U,$J,358.3,29590,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,29590,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,29591,0)
 ;;=A59.01^^83^1276^16
 ;;^UTILITY(U,$J,358.3,29591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29591,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29591,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,29591,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,29592,0)
 ;;=A64.^^83^1276^18
 ;;^UTILITY(U,$J,358.3,29592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29592,1,3,0)
 ;;=3^Venereal Disease
 ;;^UTILITY(U,$J,358.3,29592,1,4,0)
 ;;=4^A64.
 ;;^UTILITY(U,$J,358.3,29592,2)
 ;;=^5000362
 ;;^UTILITY(U,$J,358.3,29593,0)
 ;;=L81.8^^83^1277^1
 ;;^UTILITY(U,$J,358.3,29593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29593,1,3,0)
 ;;=3^Abnormal Skin Pigment
 ;;^UTILITY(U,$J,358.3,29593,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,29593,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,29594,0)
 ;;=L70.0^^83^1277^2
 ;;^UTILITY(U,$J,358.3,29594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29594,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,29594,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,29594,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,29595,0)
 ;;=L65.9^^83^1277^3
 ;;^UTILITY(U,$J,358.3,29595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29595,1,3,0)
 ;;=3^Alopecia
 ;;^UTILITY(U,$J,358.3,29595,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,29595,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,29596,0)
 ;;=L20.89^^83^1277^4
 ;;^UTILITY(U,$J,358.3,29596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29596,1,3,0)
 ;;=3^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,29596,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,29596,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,29597,0)
 ;;=D23.9^^83^1277^5
 ;;^UTILITY(U,$J,358.3,29597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29597,1,3,0)
 ;;=3^Benign Neoplasm,Skin
 ;;^UTILITY(U,$J,358.3,29597,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,29597,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,29598,0)
 ;;=L73.8^^83^1277^7
 ;;^UTILITY(U,$J,358.3,29598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29598,1,3,0)
 ;;=3^Folliculitis,Other Specified
 ;;^UTILITY(U,$J,358.3,29598,1,4,0)
 ;;=4^L73.8
 ;;^UTILITY(U,$J,358.3,29598,2)
 ;;=^5009285
 ;;^UTILITY(U,$J,358.3,29599,0)
 ;;=L28.0^^83^1277^8
 ;;^UTILITY(U,$J,358.3,29599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29599,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,29599,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,29599,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,29600,0)
 ;;=D17.30^^83^1277^9
 ;;^UTILITY(U,$J,358.3,29600,1,0)
 ;;=^358.31IA^4^2
